Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Avid Bioservices (CDMO)
NASDAQ:CDMO
Holding CDMO?
Track your performance easily
CDMO Stock Chart & Stats
Day’s Range― - ―
52-Week Range$5.90 - $12.48
Previous CloseN/A
Volume619.84K
Average Volume (3M)1.18M
Market Cap
$791.87M
Enterprise Value$807.73M
Total Cash (Recent Filing)$46.80M
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta2.23
Next Earnings
Mar 17, 2025EPS Estimate
-0.05Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.39
Shares Outstanding63,963,303
10 Day Avg. Volume1,482,491
30 Day Avg. Volume1,183,284
Standard Deviation0.18
R-Squared0.17
Alpha0.00757
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)5.26
Price to Cash Flow (P/CF)49.60
P/FCF Ratio51.80
Enterprise Value/Market Cap1.02
Enterprise Value/Revenue5.37
Enterprise Value/Gross Profit110.38
Enterprise Value/Ebitda-61.34
Forecast
1Y Price Target
$12.50Price Target Upside0.89% Upside
Rating ConsensusHold
Number of Analyst Covering3
Avid Bioservices News
PremiumCompany Announcements
Avid Bioservices Reports Revenue Growth Amid Acquisition Plans
PremiumPre-Earnings
Is CDMO a Buy, Before Earnings?
PremiumCompany Announcements
Avid Bioservices to be Acquired in $1.1 Billion DealOwnership Overview
9.68% Insiders
19.07% Mutual Funds
2.33% Other Institutional Investors
55.23% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
CDMO FAQ
What was Avid Bioservices’s price range in the past 12 months?
Avid Bioservices lowest stock price was $5.90 and its highest was $12.48 in the past 12 months.
What is Avid Bioservices’s market cap?
Avid Bioservices’s market cap is $791.87M.
When is Avid Bioservices’s upcoming earnings report date?
Avid Bioservices’s upcoming earnings report date is Mar 17, 2025 which is in 58 days.
How were Avid Bioservices’s earnings last quarter?
Avid Bioservices released its earnings results on Dec 10, 2024. The company reported -$0.27 earnings per share for the quarter, missing the consensus estimate of -$0.118 by -$0.152.
Is Avid Bioservices overvalued?
According to Wall Street analysts Avid Bioservices’s price is currently Undervalued.
Does Avid Bioservices pay dividends?
Avid Bioservices does not currently pay dividends.
What is Avid Bioservices’s EPS estimate?
Avid Bioservices’s EPS estimate is -0.05.
How many shares outstanding does Avid Bioservices have?
Avid Bioservices has 63,963,303 shares outstanding.
What happened to Avid Bioservices’s price movement after its last earnings report?
Avid Bioservices reported an EPS of -$0.27 in its last earnings report, missing expectations of -$0.118. Following the earnings report the stock price went down -0.65%.
Which hedge fund is a major shareholder of Avid Bioservices?
Among the largest hedge funds holding Avid Bioservices’s share is Royce & Associates LLC. It holds Avid Bioservices’s shares valued at 9M.
---
Avid Bioservices Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$12.50 (0.89% Upside)
$12.50 (0.89% Upside)
Blogger Sentiment
Bullish
CDMO Sentiment 100%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Increased
By 46.6K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $2.8M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.7%
Last 30 Days ▼ 4.7%
Last 30 Days ▼ 4.7%
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Positive
20 days / 200 days
Momentum
97.92%
12-Months-Change
Fundamentals
Return on Equity
-133.29%
Trailing 12-Months
Asset Growth
-28.98%
Trailing 12-Months
Company Description
Avid Bioservices
Avid Bioservices, Inc. engages in the commercial manufacturing which focuses on biopharmaceutical products derived from mammalian cell culture for culture for biotechnology and pharmaceutical companies. The firm specializes in clinical and commercial product manufacturing, purification, bulk packaging, stability testing and regulatory submissions, and support. The company was founded on June 3, 1981 and is headquartered in Tustin, CA.
---
CDMO Earnings Call
Q1 2024
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call presented a mix of positive developments, such as revenue growth, improved gross margin, and a record backlog, alongside challenges like increased net loss and higher SG&A expenses. The company's strategic efforts in business development are yielding results, yet challenges in specific segments like cell and gene therapy remain. Overall, the highlights and lowlights seem balanced.Read More>---
CDMO Stock 12 Month Forecast
Average Price Target
$12.50
▲(0.89% Upside)
Technical Analysis
Best Analysts Covering CDMO
1 Year
1 Year Success Rate
4/6 ratings generated profit
1 Year Average Return
+28.87%
reiterated a buy rating 7 months ago
Copying Paul Knight's trades and holding each position for 1 Year would result in 66.67% of your transactions generating a profit, with an average return of +28.87% per trade.
---